Journal rankings · indicator year 2019
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2019
Immunology and Microbiology journal rankings 2019
131 ranked journals · Field in Life Sciences
Immunology and Microbiology has 131 ranked journals in 2019. The median journal has an OJR of 0.95, below the world average of 1.00, down 0.01 on 2018; Q1 starts at OJR 1.33. The top three are Journal of Basic and Clinical Pharmacy, Immunity, and Nature Immunology.
Ranks and citation indicators: 2019. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2016–2018, the window the 2019 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences131 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2018. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2016–2018, the window the 2019 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2016–2018 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2010 to 2019. | Compare |
|---|---|---|---|---|---|---|---|
1Journal of Basic and Clinical PharmacyMedknow · India | 5.85Q1 | 1.00 10.50 down from 2018 | 31 | 0% | — | ||
2ImmunityCell Press · United States | 5.59Q1 | 16.69 0.06 down from 2018 | 776 | 99% | $10,400 | ||
3Nature ImmunologyNature Portfolio · United States | 4.05Q1 | 12.13 0.37 down from 2018 | 731 | 50% | $12,690 | ||
4The Journal of Experimental MedicineRockefeller University Press · United States | 3.65Q1 | 12.19 1.37 up from 2018 | 706 | 99% | — | ||
5Science ImmunologyAmerican Association for the Advancement of Science · United States | 3.54Q1 | 10.57 1.12 up from 2018 | 237 | 54% | — | ||
6Seminars in ImmunologyElsevier BV · United States | 3.20Q1 | 10.21 2.12 up from 2018 | 169 | 46% | $4,370 | ||
7Nature reviews. ImmunologyNature Portfolio · United Kingdom | 3.00Q1 | 16.23 2.33 down from 2018 | 437 | 19% | — | ||
8Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.84Q1 | 7.61 0.76 down from 2018 | 1,750 | 76% | $4,900 | ||
9Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 2.79Q1 | 8.16 1.98 up from 2018 | 183 | 16% | $5,490 | ||
10Seminars in ImmunopathologySpringer Science+Business Media · Germany | 2.67Q1 | 8.06 1.13 up from 2018 | 169 | 44% | $3,790 | ||
11Journal of AutoimmunityElsevier BV · United Kingdom | 2.45Q1 | 7.53 0.13 up from 2018 | 376 | 49% | $5,420 | ||
12Mucosal ImmunologyOAElsevier BV · United States | 2.42Q1 | 6.57 0.63 down from 2018 | 378 | 99% | $4,370 | ||
13Annual Review of ImmunologyAnnual Reviews · United States | 2.27Q1 | 22.51 0.10 down from 2018 | 81 | 58% | — | ||
14Clinical & Translational ImmunologyOAWiley · Australia | 2.20Q1 | 5.79 2.33 down from 2018 | 136 | 100% | $3,070 | ||
15International Journal for ParasitologyElsevier BV · Australia | 2.04Q1 | 3.99 0.26 up from 2018 | 298 | 44% | $2,880 | ||
16Journal of Innate ImmunityOAKarger Publishers · Switzerland | 2.04Q1 | 4.15 3.56 down from 2018 | 182 | 100% | $3,590 | ||
17Frontiers in ImmunologyOAFrontiers Media · Switzerland | 2.02Q1 | 6.24 0.50 up from 2018 | 5,601 | 100% | $3,801 | ||
18Immunity & AgeingOABioMed Central · United Kingdom | 1.82Q1 | 3.98 0.67 down from 2018 | 81 | 100% | $3,190 | ||
19Food and Waterborne ParasitologyOAElsevier BV · United States | 1.74Q1 | 3.87 0.20 up from 2018 | 30 | 100% | $2,500 | ||
20Parasites & VectorsOABioMed Central · United Kingdom | 1.67Q1 | 3.66 0.02 down from 2018 | 1,926 | 100% | $3,090 | ||
21ImmunologyWiley · United Kingdom | 1.67Q1 | 5.27 1.24 up from 2018 | 465 | 17% | $5,330 | ||
22The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.57Q1 | 5.03 0.21 up from 2018 | 2,612 | 17% | $3,500 | ||
23RetrovirologyOABioMed Central · United Kingdom | 1.52Q1 | 4.63 0.51 up from 2018 | 222 | 100% | $2,890 | ||
24BioDrugsAdis, Springer Healthcare · Switzerland | 1.51Q1 | 6.22 0.38 up from 2018 | 154 | 49% | $5,190 | ||
25Cellular and Molecular ImmunologySpringer Nature · China | 1.50Q1 | 3.95 0.82 down from 2018 | 352 | 99% | $5,190 | ||
26Infection and ImmunityOAAmerican Society for Microbiology · United States | 1.46Q1 | 3.68 0.34 up from 2018 | 953 | 97% | — | ||
27International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.45Q1 | 4.12 1.06 up from 2018 | 42 | 100% | $1,000 | ||
28International Reviews of ImmunologyTaylor & Francis · United States | 1.44Q1 | 5.45 1.18 up from 2018 | 70 | 25% | — | ||
29Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.40Q1 | 3.71 0.01 up from 2018 | 456 | 92% | $3,816 | ||
30Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.38Q1 | 5.39 1.45 up from 2018 | 321 | 33% | $4,990 | ||
31The AAPS JournalSpringer Science+Business Media · United States | 1.37Q1 | 4.23 0.35 up from 2018 | 394 | 40% | $5,090 | ||
32Ticks and Tick-borne DiseasesOAElsevier BV · Germany | 1.37Q1 | 3.10 0.21 down from 2018 | 563 | 39% | $3,010 | ||
33Cellular ImmunologyElsevier BV · Netherlands | 1.33Q1 | 4.42 1.09 up from 2018 | 376 | 38% | $3,550 | ||
34Trends in ImmunologyElsevier BV · United Kingdom | 1.33Q2 | 12.40 1.30 up from 2018 | 281 | 48% | $7,030 | ||
35Immune NetworkOASouth Korea | 1.31Q2 | 4.39 0.75 up from 2018 | 139 | 100% | — | ||
36ParasiteOAEDP Sciences · France | 1.30Q2 | 2.73 0.01 up from 2018 | 184 | 100% | $1,695 | ||
37Journal of Leukocyte BiologyOxford University Press · United States | 1.29Q2 | 3.85 0.28 down from 2018 | 689 | 50% | $3,800 | ||
38Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.29Q2 | 3.52 0.24 down from 2018 | 394 | 31% | — | ||
39Immunological ReviewsWiley · United States | 1.25Q2 | 14.72 2.15 up from 2018 | 303 | 59% | $5,000 | ||
40Psoriasis Targets and TherapyOADove Medical Press · New Zealand | 1.25Q2 | 3.71 1.59 up from 2018 | 36 | 100% | $2,320 | ||
41Parasite ImmunologyWiley · United Kingdom | 1.23Q2 | 2.14 0.61 down from 2018 | 237 | 29% | $4,220 | ||
42Pathogens and DiseaseOxford University Press · United Kingdom | 1.22Q2 | 2.82 0.40 up from 2018 | 330 | 57% | $3,297 | ||
43Molecular ImmunologyElsevier BV · Netherlands | 1.18Q2 | 3.87 0.60 up from 2018 | 773 | 23% | $3,340 | ||
44Clinical ImmunologyElsevier BV · Netherlands | 1.17Q2 | 3.32 0.06 down from 2018 | 564 | 18% | $4,400 | ||
45Zoonoses and Public HealthWiley · Germany | 1.16Q2 | 2.66 0.17 up from 2018 | 293 | 32% | $4,880 | ||
46Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.14Q2 | 2.71 0.12 up from 2018 | 129 | 100% | $3,490 | ||
47Vector-Borne and Zoonotic DiseasesMary Ann Liebert, Inc. · United States | 1.13Q2 | 2.38 0.06 down from 2018 | 410 | 36% | — | ||
48Immunologic ResearchSpringer Science+Business Media · United States | 1.12Q2 | 2.97 0.01 up from 2018 | 281 | 18% | $2,890 | ||
49Immunology LettersElsevier BV · Netherlands | 1.11Q2 | 3.54 0.75 up from 2018 | 462 | 17% | $3,290 | ||
50European Journal of ImmunologyWiley · Germany | 1.09Q2 | 3.22 0.07 down from 2018 | 788 | 76% | $4,550 |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2019. Corpus-wide, 83.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
45 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2016–2018, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2019. Publication window: 2016–2018. How these summaries are calculated
- Ranked journals
- 131
- Window papers (baseline)
- 123,895 -0.1% from indicator year 2016
- Median OJR
- 0.948 -13.2% from indicator year 2016
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2016–2018 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.